Mark Melzer
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- Irene Petersen (3 shared papers)Catherine Welch (8 shared papers)W. R. Gransden (2 shared papers)Susannah Eykyn (2 shared papers)S Chinn (1 shared paper)Sandra Lacey (4 shared papers)Greta Rait (2 shared papers)Richard W. Toner (1 shared paper)
- Journals
- Journal of Infection (7 papers)Postgraduate Medical Journal (6 papers)Journal of Hospital Infection (4 papers)Infection (3 papers)International Journal of Infectious Diseases (2 papers)
- Partner nations
- United KingdomGermanyCanada
In The Last Decade
Mark Melzer
42 papers receiving 799 citations
Peers
Comparison fields: 5 of 82
- Applied Microbiology and Biotechnology 130
- Molecular Medicine 225
- Clinical Biochemistry 181
- Infectious Diseases 251
- Endocrinology 68
Countries citing papers authored by Mark Melzer
This map shows the geographic impact of Mark Melzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Melzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Melzer more than expected).
Fields of papers citing papers by Mark Melzer
This network shows the impact of papers produced by Mark Melzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Melzer. The network helps show where Mark Melzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Melzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 215 | |
| 2 | 2003 | 192 | |
| 3 | 2007 | 92 | |
| 4 | 2013 | 52 | |
| 5 | 2006 | 44 | |
| 6 | 2013 | 40 | |
| 7 | 2011 | 24 | |
| 8 | 2017 | 19 | |
| 9 | 2018 | 18 | |
| 10 | 2018 | 12 | |
| 11 | 1998 | 10 | |
| 12 | 2013 | 10 | |
| 13 | 2000 | 9 | |
| 14 | 2009 | 8 | |
| 15 | 2000 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2008 | 5 | |
| 19 | 2010 | 5 | |
| 20 | 2000 | 5 |
About Mark Melzer
Mark Melzer is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Epidemiology, having authored 44 papers that have together received 833 indexed citations. Recurring topics across this work include Urinary Tract Infections Management (7 papers), Antibiotic Resistance in Bacteria (7 papers), Pneumonia and Respiratory Infections (5 papers), Infective Endocarditis Diagnosis and Management (5 papers), Tuberculosis Research and Epidemiology (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Infectious Diseases and Tuberculosis (5 papers) and Mycobacterium research and diagnosis (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (130 citations), Molecular Medicine (225 citations), Clinical Biochemistry (181 citations), Infectious Diseases (251 citations) and Endocrinology (68 citations). Mark Melzer has collaborated with scholars based in United Kingdom, Germany and Canada. Frequent co-authors include Irene Petersen, Catherine Welch, W. R. Gransden, Susannah Eykyn, S Chinn, Sandra Lacey, Greta Rait, Richard W. Toner, Rosalynn Ord and Julie Watson. Their work appears in journals such as Journal of Infection, Postgraduate Medical Journal, Journal of Hospital Infection, Infection and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.